BOT Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea - 13th Oct 2022, 9:47am

annb0t

annb0t

Top 20
BOT Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea
Price Sensitive: Y
Date: 13th Oct 2022, 9:47am

>>> Read announcement: Google: BOT Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
BOT Ann: Investor Presentation and Investor Meetings - 31st Oct 2023, 9:45am
Replies
0
Views
92
annb0t
annb0t
annb0t
BOT Ann: September 2023 Quarterly Activities Report and Appendix 4C - 31st Oct 2023, 9:00am
Replies
0
Views
71
annb0t
annb0t
annb0t
BOT Ann: Botanix Partners with Telehealth Provider UpScriptHealth - 24th Oct 2023, 9:43am
Replies
0
Views
129
annb0t
annb0t
annb0t
BOT Ann: FDA Approves SOFDRA as Trade Name for Sofpironium Bromide - 17th Oct 2023, 9:45am
Replies
0
Views
107
annb0t
annb0t
annb0t
BOT Ann: Section 708A(5)(e) Notice - 16th Oct 2023, 7:31pm
Replies
0
Views
109
annb0t
annb0t
Top Bottom